Regulated Information

Period

recent search

Showing: 105 of 148 Regulated Information

IPSEN - Buy-back programme - Art 5 of MAR - Week 45 - 2025
IPSEN – Buy-back programme – Art 5 of MAR – Week 45 – 2025


Ipsen - October 2025 - Monthly information relative to the total number of voting rights and shares composing the share capital
Ipsen – October 2025 – Monthly information relative to the total number of voting rights and shares composing the share capital

Monthly information relative to the total number of voting rights and shares composing the share capital


IPSEN - Buy-back programme - Art 5 of MAR - Week 44 - 2025
IPSEN – Buy-back programme – Art 5 of MAR – Week 44 – 2025


IPSEN - Buy-back programme - Art 5 of MAR - Week 43 - 2025
IPSEN – Buy-back programme – Art 5 of MAR – Week 43 – 2025


Ipsen to acquire ImCheck Therapeutics, expanding its leadership in oncology, strengthening its pipeline
Ipsen to acquire ImCheck Therapeutics, expanding its leadership in oncology, strengthening its pipeline

PARIS AND MARSEILLE, FRANCE, 22 October 2025 – Ipsen (Euronext: IPN; ADR: IPSEY) and ImCheck Therapeutics today announced they have entered into a definitive share purchase agreement in which Ipsen will acquire all issued and outstanding shares of ImCheck Therapeutics,…


1 2 3 4 30